Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I
Medtronic Cardiac Rhythm Disease Management · Decision date Oct 5, 2026
What did the FDA decide?
The FDA record for P980016/S966 is a 30-day notice for a process change involving the manufacturer, sterilizer, packager or supplier, with the reported purpose 'to qualify new manufacturing equipment.' The change therefore concerns manufacturing equipment rather than a clinical or labeling element. The record does not identify the specific equipment, where the work is performed, or what technical change the qualification involves.
S966 is a supplement to PMA P980016, which the record ties to Cobalt MRI ICD and Cobalt XT MRI ICD systems and Crome MRI ICD devices, under product code LWS for non-CRT implantable cardioverter defibrillators, filed by Medtronic Cardiac Rhythm Disease Management. The decision date is 2026-10-05 and the decision is 'OK30.' The stated purpose is the applicant's reported basis for the notice, not independent evidence of safety or clinical effectiveness, and this supplement does not constitute approval of the entire system.
FDA approval order statement
to qualify new manufacturing equipment
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 5, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980016/S966
- Regulatory pathway
- PMA supplement
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Oct 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980016 · Original PMA
VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS
P980016/S966 received
Application receipt date recorded by FDA.
P980016/S965 · Related supplement
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
P980016/S966 · FDA decision
30-Day Notice
P980016/S967 · Related supplement
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
P980016/S964 · Related supplement
Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I
Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA approval | Oct 9, 1998 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S965 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Sep 25, 2026 | FDA |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P980016/S966
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




